- Corcept Chief Development Officer William Guyer sold 20,000 shares on April 7 at a weighted average price of $40.97.
- He exercised options for 20,000 shares at $21.65 on same day.
- Guyer held 2,231 shares following transactions.
- He held 190,000 stock options following exercise.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-148497), on April 08, 2026, and is solely responsible for the information contained therein.
Comments